文献速递耳科与耳神经头颈外科

颞骨癌手术治疗现状:基于Cosmos数据库的分析

Contemporary Treatment Patterns in Surgically Treated Temporal Bone Cancer.
PubMed 文献 · Laryngoscope · 2026-08-17

本研究基于Cosmos数据库(2015-2024)分析811例手术治疗的颞骨恶性肿瘤患者,描述其社会人口学特征及治疗模式。患者平均年龄70.9岁,82.1%为男性,89.3%为白人,鳞状细胞癌最常见(63.4%)。56.4%接受腮腺切除和/或颈淋巴结清扫,23.1%接受术后放疗;腮腺切除、颈淋巴结清扫及联合手术与接受术后放疗的 odds 升高相关。

要点

  • 颞骨癌手术患者以老年白人男性为主,鳞状细胞癌占63.4%。
  • 56.4%接受腮腺切除和/或颈淋巴结清扫,术后放疗占23.1%。
  • 腮腺切除、颈清扫及联合手术与术后放疗 odds 升高相关。

核心结论

  • 颞骨癌主要影响老年白人男性,术后放疗是最常用的辅助治疗,且与更广泛的手术管理相关,可能反映疾病范围更大。

研究设计与样本

  • 回顾性数据库分析,使用Cosmos数据库(2015-2024),通过ICD-10和CPT代码识别811例手术治疗的颞骨恶性肿瘤患者。

主要发现

  • 患者平均年龄70.9岁,666例(82.1%)为男性,726例(89.5%)为非西班牙裔,724例(89.3%)为白人。
  • 鳞状细胞癌为最常见组织学亚型(63.4%)。
  • 327例(40.3%)居住于南部,235例(29.0%)居住于中西部,74.1%居住于大都市区。
  • 56.4%的患者接受腮腺切除、颈淋巴结清扫或两者联合。
  • 术后放疗是最常用辅助治疗(23.1%),免疫治疗和单纯化疗很少使用。

关键数值与推荐

  • 单变量分析显示,腮腺切除(OR=1.73,95%CI:1.02-2.89)、颈淋巴结清扫(OR=3.29,95%CI:1.78-5.99)及联合手术(OR=3.13,95%CI:2.13-4.65)与接受术后放疗的 odds 升高相关。

临床怎么用

  • 对于接受腮腺切除、颈淋巴结清扫或联合手术的颞骨癌患者,应考虑到术后放疗的可能性更高,可能需多学科讨论辅助治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To characterize the sociodemographic features of patients with temporal bone carcinoma and evaluate current treatment patterns. METHODS: This study analyzed data from the Cosmos database (2015-2024) to identify patients with surgically treated temporal bone malignancies using ICD-10 codes (C44.21, C44.22, and C44.29) and CPT codes for external auditory canal excision, temporal bone resection (69535), and mastoidectomy procedures. Demographic, clinical, and treatment variables, including parotidectomy, neck dissection, and perioperative therapy, were extracted. Univariable analyses were performed to assess factors associated with receipt of postoperative radiation therapy. RESULTS: A total of 811 patients were included. The mean age was 70.9 years, and 666 patients (82.1%) were male, non-Hispanic (726, 89.5%), and White (724, 89.3%). Squamous cell carcinoma was the most common histological subtype (63.4%). Patients most commonly resided in the South (327, 40.3%) and Midwest (235, 29.0%), with 74.1% residing in metropolitan areas. Socioeconomic status and social vulnerability index distributions were relatively even. Overall, 56.4% of patients underwent parotidectomy, neck dissection, or both. Postoperative radiation therapy was the most frequently utilized adjuvant treatment (23.1%), while immunotherapy and chemotherapy alone were rarely used. On univariable analysis, parotidectomy (OR = 1.73, 95% CI: 1.02-2.89), neck dissection (OR = 3.29, 95% CI: 1.78-5.99), and combined procedures (OR = 3.13, 95% CI: 2.13-4.65) were associated with higher odds of receiving postoperative radiation. CONCLUSION: Temporal bone carcinoma primarily affects older, White male patients. Postoperative radiation therapy is the most frequently utilized adjuvant treatment and is associated with more extensive surgical management, likely reflecting greater disease extent.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Rowell R, Wen CZ, Bzhilyanskaya V, et al. Contemporary Treatment Patterns in Surgically Treated Temporal Bone Cancer. Laryngoscope. 2026. PMID: 42606149. doi:10.1002/lary.70831

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。